Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol
暂无分享,去创建一个
E. Boerwinkle | Julie A. Johnson | R. Cooper-DeHoff | A. Beitelshees | J. Gums | Y. Gong | A. Chapman | L. McIntyre | A. Morse | C. Petucci | S. Gardell | T. Garrett | R. Frye | P. Borum | J. Culver | S. Turner | Liming Weng